Description

The global bioanalytical testing service market is poised to grow by US$ 1,816.0 million during 2022-2028, progressing at a CAGR of 7.8% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for bioanalytical testing service. The global bioanalytical testing service market is segmented on the basis of molecule type, workflow, test type, and region. By molecule type, the global bioanalytical testing service market has been segmented into large molecules, small molecules. In 2021, the small molecules segment made up the largest share of revenue generated by the bioanalytical testing service market. Based upon workflow, the global bioanalytical testing service market is categorized into sample preparation, sample analysis, others. On the basis of test type, the global bioanalytical testing service market has been segmented into absorption, distribution, metabolism, and excretion (ADME), bioavailability and bioequivalence studies, pharmacodynamics (PD), pharmacokinetics (PK), others. Geographically, the global bioanalytical testing service market is segmented into North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

The global bioanalytical testing service market is highly competitive. The leading players in the bioanalytical testing service market include Almac Group Limited, Charles River Laboratories Inc., Eurofins Scientific SE, Frontage Laboratories Inc, ICON plc, Intertek Group plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (LabCorp), Medpace Holdings Inc., PPD Inc. (Thermo Fisher Scientific Inc.), SGS SA, Syneos Health Inc., WuXi AppTec Co. Ltd. Competitive landscape gives a description of the competitive nature of the global bioanalytical testing service market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the bioanalytical testing service market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Molecule type: large molecules, small molecules
Workflow: sample preparation, sample analysis, others
Test type: absorption, distribution, metabolism, and excretion (ADME), bioavailability and bioequivalence studies, pharmacodynamics (PD), pharmacokinetics (PK), others
Region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028
Company mentioned: Almac Group Limited, Charles River Laboratories Inc., Eurofins Scientific SE, Frontage Laboratories Inc, ICON plc, Intertek Group plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (LabCorp), Medpace Holdings Inc., PPD Inc. (Thermo Fisher Scientific Inc.), SGS SA, Syneos Health Inc., WuXi AppTec Co. Ltd.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global bioanalytical testing service market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Bioanalytical testing service market overview
Part 3. Market breakdown by molecule type
– Large molecules
– Small molecules
Part 4. Market breakdown by workflow
– Sample preparation
– Sample analysis
– Others
Part 5. Market breakdown by test type
– Absorption, distribution, metabolism, and excretion (ADME)
– Bioavailability and bioequivalence studies
– Pharmacodynamics (PD)
– Pharmacokinetics (PK)
– Others
Part 6. Market breakdown by region
– North America
– Europe
– Asia-Pacific
– MEA (Middle East and Africa)
– Latin America
Part 7. Key companies
– Almac Group Limited
– Charles River Laboratories, Inc.
– Eurofins Scientific SE
– Frontage Laboratories, Inc
– ICON plc
– Intertek Group plc
– IQVIA Holdings Inc.
– Laboratory Corporation of America Holdings (LabCorp)
– Medpace Holdings, Inc.
– PPD Inc. (Thermo Fisher Scientific Inc.)
– SGS SA
– Syneos Health, Inc.
– WuXi AppTec Co., Ltd.
About StrategyHelix
Disclaimer